Colinz Laboratories (531210.BO) Stock Price
Colinz Laboratories Price
Revenue at Colinz Laboratories has contracted by 0.5% per year over the past 14 years to 61.36 M INR. Earnings per share have grown at 16.5% per year over the last 14 years. Colinz Laboratories's net margin stands at 8.4%, up from 4.9% several years earlier.
Colinz Laboratories stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Colinz Laboratories business model & stock analysis
Frequently asked questions about Colinz Laboratories
Converted at the current exchange rate, the Colinz Laboratories share trades at 0.64 EUR (65.50 INR).
The revenue of Colinz Laboratories is 61.36 M INR. This figure is based on current financial data and reflects the company's business performance.
The profit of Colinz Laboratories is 5.15 M INR. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Colinz Laboratories is currently 32.07. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Colinz Laboratories stock.
The price-to-sales ratio (P/S) of Colinz Laboratories is currently 2.69. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Colinz Laboratories stock.
The Eulerpool Quality Score for Colinz Laboratories is 2/10.
The ISIN of Colinz Laboratories is INE923C01011. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Colinz Laboratories is 531210.BO. The ticker symbol is used to trade Colinz Laboratories shares on the stock exchange.
Colinz Laboratories stock
Colinz Laboratories Peer Group
Colinz Laboratories FIGI
All fundamentals and in-depth analysis of Colinz Laboratories
Our stock analysis for Colinz Laboratories stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Colinz Laboratories. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.